Evaluation of Efficacy/Safety of EVE-PMS Skin Test Panel
Status:
Unknown status
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The EVE-PMS technology is intended for determination of intolerance or sensitivity to sex
hormones, among women suffering from severe PreMenstrual Syndrome (PMS).
The system includes skin testing panel for identification of hormones to which the patients
might be sensitive. Tests are applied close to the ovulation period and the skin reaction is
examined in 20 minutes, 48 hours and daily during the following month. Results of skin tests
and patient's history will determine the value of EVE-PMS Skin-Test Panel as a diagnostic
tool for severe PMS patients.